8-K: Hercules Capital Announces Record Q2 Fundings and Declares $0.48 Dividend

Hercules Capital reported record second-quarter fundings and investment income, alongside declaring a total cash distribution of $0.48 per share.

Summary

• Hercules Capital announced its financial results for the second quarter of 2024, highlighting record total gross fundings of $461.5 million, a 28.7% increase year-over-year.
• The company also achieved record total investment income of $125.0 million, a 7.5% increase year-over-year, and net investment income (NII) of $82.4 million, or $0.51 per share, an 8.8% increase year-over-year.
• Hercules' NII provided 128% coverage of the base cash distribution, and the company's undistributed earnings spillover reached $145.0 million, or $0.89 per share.
• The company's assets under management grew to approximately $4.6 billion, a 14.7% increase year-over-year.
• The board of directors declared a total cash distribution of $0.48 per share for the second quarter, consisting of a $0.40 base distribution and a $0.08 supplemental distribution.
• The company's net asset value (NAV) per share decreased by 1.7% to $11.43 from the previous quarter.
• Hercules received approval for its fourth SBIC license, providing access to $175 million of additional growth capital.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, record fundings, and increased investment income. The approval of the fourth SBIC license is also a positive development. However, the decrease in NAV per share and unrealized losses temper the overall sentiment slightly.

Positives

• Hercules Capital experienced significant growth in fundings and investment income during the second quarter of 2024.
• The company's net investment income provides strong coverage for its base cash distribution.
• The increase in early loan repayments indicates strong performance from portfolio companies.
• The company maintains a strong liquidity position with $482 million available.
• The approval of the fourth SBIC license provides access to additional capital for future growth.
• The company's portfolio is primarily composed of first lien senior secured loans with floating interest rates.

Negatives

• The company's net asset value (NAV) per share decreased by 1.7% from the previous quarter.
• The company recorded net unrealized depreciation of $34.7 million during the quarter.
• The company had net realized losses of $5.8 million in Q2 2024.
• The weighted average grade of the debt investment portfolio decreased slightly from 2.16 to 2.18.
• The company has two debt investments on non-accrual with a fair value of $32.1 million.

Risks

• The company's portfolio companies may require additional funding, which could impact Hercules' investment performance.
• The company's credit grading policy may lead to downgrades of portfolio companies.
• Fluctuations in interest rates could impact the company's net investment income.
• Unrealized depreciation on investments could negatively affect the company's net asset value.
• The company's leverage ratios could pose risks if not managed effectively.
• The company's reliance on early loan repayments could impact future income if these repayments decrease.

Future Outlook

The company aims to maintain its disciplined growth strategy, leveraging its strong liquidity and moderate leverage to capitalize on market opportunities while adhering to stringent underwriting standards. The fourth SBIC license is expected to provide further flexibility and liquidity to support growth.

Management Comments

• Scott Bluestein, chief executive officer and chief investment officer of Hercules, stated that the company's exceptional start to 2024 continued through the second quarter with record gross fundings of $1.07 billion for the first half of 2024, an increase of nearly 28% year-over-year.
• Bluestein also noted that the company's disciplined growth strategy has put them in an advantageous competitive position to be opportunistic in the market while maintaining stringent underwriting standards.
• Bluestein concluded that the fourth SBIC license will provide further flexibility and liquidity to be able to continue to support the company's growth-stage ecosystem.

Industry Context

Hercules Capital's strong performance reflects the continued demand for venture debt financing in the technology and life sciences sectors. The company's focus on senior secured loans to high-growth, innovative companies positions it well within the current market environment. The increase in early loan repayments suggests that the portfolio companies are performing well and potentially reaching liquidity events.

Comparison to Industry Standards

• Hercules Capital's 14.7% effective yield is competitive within the BDC sector, which typically ranges from 10% to 15%.
• The company's net investment income growth of 8.8% year-over-year is strong compared to some peers, but some BDCs have seen higher growth rates in the current environment.
• The company's leverage ratios are within the typical range for BDCs, but the net regulatory leverage of 83.9% is on the higher end of the spectrum.
• Compared to Ares Capital Corporation (ARCC), a major BDC, Hercules has a higher focus on venture debt, while ARCC has a more diversified portfolio. ARCC's leverage is also typically lower than Hercules.
• Main Street Capital (MAIN) is another comparable BDC, but it has a lower yield and a more conservative approach to lending compared to Hercules.
• The increase in early loan repayments is a positive sign, but it is important to note that this can be volatile and may not be sustainable in the long term. Other BDCs such as TSLX have also seen similar increases in early repayments.
• The decrease in NAV per share is a concern, but it is not uncommon in the current market environment. Other BDCs have also seen similar decreases in NAV due to unrealized losses.

Stakeholder Impact

• Shareholders will receive a total cash distribution of $0.48 per share.
• Employees may benefit from the company's strong financial performance.
• Portfolio companies will continue to receive funding from Hercules.
• Creditors may view the company's strong liquidity position favorably.

Next Steps

• The company will continue to execute its disciplined growth strategy.
• The company will focus on maintaining ample liquidity and moderate leverage.
• The company will continue to evaluate new investment opportunities.
• The company will utilize the new SBIC license to access additional capital.

Key Dates

Keywords

venture debt, specialty finance, business development company, BDC, investment income, net investment income, fundings, distributions, leverage, SBIC, portfolio companies, technology, life sciences